相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
Ling Li et al.
CANCER CELL (2012)
CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression
Christian Schuerch et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Infection-Induced Myelopoiesis during Intracellular Bacterial Infection Is Critically Dependent upon IFN-γ Signaling
Katherine C. MacNamara et al.
JOURNAL OF IMMUNOLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors
Claude Capron et al.
BLOOD (2010)
Chronic myelogenous leukemia maintains specific CD8+ T cells through IL-7 signaling
Sabine Mumprecht et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Interferon-γ-mediated pathways are induced in human CD34+ haematopoietic stem cells
Katharina Kurz et al.
IMMUNOBIOLOGY (2010)
Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
Megan T. Baldridge et al.
NATURE (2010)
Induction of an IL7-R+c-Kithi myelolymphoid progenitor critically dependent on IFN-γ signaling during acute malaria
Nikolai N. Belyaev et al.
NATURE IMMUNOLOGY (2010)
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Yingzi Wang et al.
SCIENCE (2010)
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells
Sabine Mumprecht et al.
BLOOD (2009)
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
Sabine Mumprecht et al.
BLOOD (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Niche recycling through division-independent egress of hematopoietic stem cells
Deepta Bhattacharya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Detection of functional haematopoietic stem cell niche using real-time imaging
Yucai Xie et al.
NATURE (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Chronic myeloid leukemia stem cells
Edward Kavalerchik et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
Getting to the stem of chronic myeloid leukaemia
Michael Savona et al.
NATURE REVIEWS CANCER (2008)
Uncertainty in the niches that maintain haematopoietic stem cells
Mark J. Kiel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl,2-methyl,1,2,4-thiadiazolidine,3,5-dione (TDZD-8)
Monica L. Guzman et al.
BLOOD (2007)
Leukemia stem cells in a genetically defined murine model of blast-crisis CML
Sarah J. Neering et al.
BLOOD (2007)
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Murine allogeneic in vivo stem cell homing
Gerald A. Colvin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections
Sabine Mumprecht et al.
BLOOD (2006)
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
Daniela S. Krause et al.
NATURE MEDICINE (2006)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Elimination of chronic viral infection by blocking CD27 signaling
Matthias Matter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Antigen-specific cellular immunotherapy of leukemia
A Van Driessche et al.
LEUKEMIA (2005)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Characterization of clonogenic multiple myeloma cells
W Matsui et al.
BLOOD (2004)
Characterization of acute lymphoblastic leukemia progenitor cells
CV Cox et al.
BLOOD (2004)
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions
AM Raiola et al.
BONE MARROW TRANSPLANTATION (2003)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
RE Clark et al.
BLOOD (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse
S Carlens et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease
B Ludewig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)